Full-Time

Staff Product Manager

Chromium Instruments

Posted on 3/20/2024

10x Genomics

10x Genomics

1,001-5,000 employees

Biotechnology tools for genomic research

Compensation Overview

$165k - $223k/yr

+ Equity Grants + Annual Bonus Program

Senior

Pleasanton, CA, USA

Category
Product Management
Product
Required Skills
Market Research
Sales
Product Management
Marketing
Requirements
  • BS in life science field – with experience in NGS methods
  • 6 years of experience in product management or marketing in Life Sciences or Clinical industry.
  • Strong technical knowledge of genomics, and/or next generation sequencing and molecular biology products
  • Experience in hardware product management required including product launch
  • Must have experience in customer interactions in either a Sales, Support, or Marketing function
  • Must have experience creating financial models and business cases; strong Excel skills
  • Experience conducting market research and developing detailed product requirements
  • Demonstrated ability to develop long-term product strategies and go-to-market plans
  • Must have proficient written, communication and presentation skills with the ability to present to diverse audiences
  • Experience working in highly technical and cross-functional teams covering various internal organizations
  • Ability to influence across the organization at all levels
  • Exceptional time and project management skills and ability to prioritize competing requests
  • Self-starter willing to work in a fast-paced environment
  • Must be willing to travel up to 30%
Responsibilities
  • Defines and maintains business plan for single cell instrumentation (benchtop and automation), including developing and integrated instrument strategy and roadmap and sustaining projects to drive improvements
  • Interfaces with sales and customers regularly to characterize market needs and gaps, opportunities and trends, competitive and technology landscape for the single cell platform
  • Serves as primary customer advocate during product development and sustaining projects to regularly evaluate feature requests and product enhancements; drives tradeoff decisions
  • Works closely with manufacturing operations, quality, and support on product issues to ensure products meet customer expectations
  • Collaborates with Regional Marketing, Global Marketing counterparts and Business Development to support marketing and sales enablement activities, as well activities related to strategic 3rd party partnerships
  • Marketing lead for the instrument life cycle management team, defining prioritization, scope, and resourcing of sustaining projects for single cell instrumentation
  • Educates sales and regional marketing on the single cell product line positioning and specifications
  • Designs / implements effective market and forecast models for single cell instrumentation with stakeholders to provide granularity at the regional, market, and segment level
  • Sets pricing strategy and monitors key performance indicators to ensure single cell instrument portfolio delivers against product profitability goals

10x Genomics provides specialized tools for genomic research, focusing on single-cell analysis, spatial gene expression, and immune profiling. Their products, including laboratory equipment and software, help researchers analyze genetic information in detail, which is essential for understanding complex biological systems. Unlike competitors, 10x Genomics emphasizes high-resolution genomic data to support personalized medicine. The company's goal is to empower scientists with the necessary tools to explore the complexities of the human genome.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Pleasanton, California

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Recent innovations in Visium and Xenium enhance their spatial biology leadership.
  • AI integration in genomics research boosts their personalized medicine capabilities.
  • Patent victories secure their technological advancements and market position.

What critics are saying

  • Increased competition from companies like Ultima Genomics threatens market share.
  • Recent layoffs may impact employee morale and innovation.
  • Ongoing patent litigation could lead to significant legal expenses.

What makes 10x Genomics unique

  • 10x Genomics offers cutting-edge single-cell and spatial analysis tools.
  • Their technology enables high-resolution genomic data crucial for personalized medicine.
  • They have a strong patent portfolio protecting their innovative genomic solutions.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive health benefits

Generous time off

Parental leave

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Livermore Vine
May 28th, 2025
Pleasanton-based 10x Genomics laying off 93 local workers

Pleasanton-based 10x Genomics laying off 93 local workers.

Cache Valley Daily
May 14th, 2025
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker

10x Genomics announces patent litigation settlement agreement with Bruker.

PR Newswire
May 5th, 2025
Psomagen Selected As Key Service Provider, Will Utilize Ultima Genomics' Ug 100™ Sequencer To Accelerate Chan Zuckerberg Initiative'S Billion Cells Project

ROCKVILLE, Md., May 5, 2025 /PRNewswire/ -- Psomagen Inc., a multiomics service laboratory serving academic, pharma, biotech, and clinical customers, will join the Billion Cells Project led by the Chan Zuckerberg Initiative (CZI). The Billion Cells Project aims to develop a landmark single-cell dataset of one billion cells that will be used to train new AI models to advance researchers' understanding of cellular behavior and gene function. Psomagen has begun providing services to participating researchers in April. The project includes collaborations with several other technology partners, including Ultima Genomics, 10x Genomics and Scale Biosciences. Su Hong, CEO of Psomagen, says, "This project represents a transformative step in biomedical research, enabling the identification of novel therapeutic targets and guiding drug development with unparalleled precision. By leveraging AI-powered analysis on vast single-cell datasets, we aim to accelerate the discovery of new ways to restore diseased cells to health

Stock Titan
Mar 6th, 2025
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer

Cardillo joins from 10x Genomics, where she served as Vice President of Corporate Communications.

PR Newswire
Mar 3rd, 2025
10X Genomics Secures Injunction Against Parse Biosciences' Planned Atac Products

10x Genomics' ATAC-Seq patents found valid and infringedPLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the United States District Court for the District of Delaware, Parse agreed - a week before trial was to start - to a worldwide permanent injunction that prevents it from making, using, selling or offering for sale its planned ATAC and ATAC-Multiome Single Cell products. As part of this consent agreement, Parse admitted that 10x's ATAC-seq patents are valid, enforceable and infringed by Parse's use of ATAC-seq methods and compositions."This development further validates the strength of our broad patent portfolio, which helps protect and preserve the world-class innovation engine at 10x," said Eric S. Whitaker, Chief Legal Officer of 10x Genomics. "We are pleased with this resolution on ATAC as we continue to defend the asserted Brenner patents on appeal."The company's litigation against Parse's gene expression products remains ongoing, with additional asserted patents under appeal. Following entry of the injunction, the trial scheduled for March 2025 concerning 10x's remaining patent infringement claims against Parse has been stayed pending those appeals.10x Genomics is committed to defending its intellectual property and investing in groundbreaking technologies that empower researchers worldwide.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health

INACTIVE